HIV

Bristol Myers settles HIV antitrust suit, but J&J, Gilead still await their day in court
Fierce Pharma
Fri, 04/15/22 - 01:54 pm
JNJ
Bristol Myers Squibb
Gilead Sciences
HIV
legal
anticompetitive practices
generics
Physician poll finds ultralong-acting regimens and home administration could transform HIV market
Fierce Pharma
Tue, 04/5/22 - 11:02 am
HIV
physicians
GSK
Gilead Sciences
ViiV Healthcare
After FDA hold, CytoDyn will appeal for pharma partnerships to save leronlimab
Fierce Biotech
Thu, 03/31/22 - 10:39 am
CytoDyn
FDA
clinical holds
HIV
leronlimab
With competitors circling, ViiV wins another label update for long-acting HIV injectable Cabenuva
Endpoints
Thu, 03/24/22 - 08:33 pm
ViiV Healthcare
GSK
FDA
Cabenuva
HIV
Janssen
Moderna hits the gas as it begins dosing of 2nd HIV vaccine
Fierce Biotech
Mon, 03/14/22 - 11:40 pm
Moderna Therapeutics
MRNA
HIV
vaccines
clinical trials
Bottlenecks are slowing switch to GSK's long-acting HIV injectable Cabenuva: clinician
Fierce Pharma
Tue, 03/8/22 - 10:57 pm
GSK
HIV
Cabenuva
supply chain
distribution
FDA rejects Gilead's closely watched HIV drug
BioPharma Dive
Tue, 03/1/22 - 10:05 pm
Gilead Sciences
HIV
FDA
lenacapavir
GSK to get $1.25 bln to settle HIV drug patent row with Gilead
Reuters
Wed, 02/2/22 - 11:01 am
GSK
Gilead Sciences
HIV
Biktarvy
patents
ViiV Healthcare gets FDA nod for two-month dosing of Cabenuva to treat HIV
Pharmaceutical Business Review
Wed, 02/2/22 - 10:57 am
ViiV Healthcare
FDA
HIV
Cabenuva
Blockbuster cancer med Keytruda may help flush out dormant HIV, suggesting a new way to treat long-running epidemic
Fierce Biotech
Thu, 01/27/22 - 11:38 pm
HIV
Merck
Keytruda
Vir expands partnership with Gates Foundation, adding $50M for HIV and malaria antibody research initiative
Endpoints
Sun, 01/16/22 - 03:50 am
Vir Biotechnology
vaccines
Gates Foundation
HIV
malaria
FDA slaps a hold on Gilead's injectable HIV treatment over concerns about potential glass contaminants
Endpoints
Wed, 12/22/21 - 11:01 am
Gilead Sciences
FDA
HIV
lenacapavir
clinical trials
clinical hold
FDA clears first long-acting HIV-prevention injectable, giving ViiV claim to historic OK
Endpoints
Tue, 12/21/21 - 10:24 am
FDA
HIV
PrEP
Apretude
GSK
ViiV Healthcare
Digital pill tracks HIV PrEP adherence with 98% accuracy
Pharmaforum
Thu, 12/9/21 - 10:38 am
digital pills
HIV
PrEP
Gilead Sciences
Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multipronged R&D strategy
Fierce Biotech
Tue, 12/7/21 - 10:43 am
Merck
HIV
clinical trials
MK-8507
GSK's ViiV looks to future of injectable HIV treatment as long-acting PrEP decision looms
Fierce Pharma
Tue, 11/30/21 - 11:24 pm
ViiV Healthcare
GSK
HIV
PrEP
cabotegravir
Merck pauses 'very important' HIV program after seeing red flag in phase 2 trial of once-weekly combo
Fierce Biotech
Fri, 11/19/21 - 10:54 am
Merck
HIV
MK-8507
clinical trials
Exavir Aims CRISPR Program at HIV, Sees Powerful Preclinical Results
BioSpace
Wed, 11/10/21 - 10:47 am
HIV
Exavir Therapeutics
gene editing
CRISPR
GSK's ViiV turns to Black women's experiences in latest season of award-winning podcast
Fierce Pharma
Tue, 11/9/21 - 10:35 am
GSK
ViiV Healthcare
HIV
AIDS
podcasts
pharma marketing
Gilead Sciences : Study Data Of Biktarvy In People Living With HIV Show High Effectiveness
NASDAQ
Fri, 10/29/21 - 11:05 am
Gilead Sciences
Biktarvy
HIV
RWE

Pages